DTIL Financials
Precision BioSciences Inc - Financial statements & key metrics
Stock Price
$7.34
Market Cap
$48.12M
P/E Ratio
7.0
EPS
$-8.96
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$68.70M
Gross Profit
-
Operating Income
-
Net Income
$7.17M
EPS (Diluted)
$1.04
Balance Sheet Highlights
Total Assets
$136.39M
Total Liabilities
$80.00M
Shareholders Equity
-
Cash & Equivalents
$85.90M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-58.45M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-158976.9%
ROE
-205.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is DTIL revenue?
DTIL's most recent quarterly revenue was $68.70M. Annual revenue can be calculated by summing the four most recent quarters.
Is DTIL profitable?
DTIL reported a profit of $7.17M in the most recent quarter.
What is DTIL market cap?
DTIL has a market capitalization of $48.12M, making it a small-cap stock.
Does DTIL have debt?
View DTIL's balance sheet for debt information.
What is DTIL cash flow?
Cash flow data is available in the full financial statements.